SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India informs about press release

01 Mar 2025 Evaluate
Sanofi India has informed that it enclosed copies of the Newspaper publication of Financial Results for the quarter and year ended 31st December 2024, of the Company published on 1st March 2025, in Business Standard and Sakal newspapers.

The above information is a part of company’s filings submitted to BSE.

Sanofi India Share Price

3530.60 -56.60 (-1.58%)
22-Apr-2026 09:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.30
Dr. Reddys Lab 1216.20
Cipla 1230.10
Zydus Lifesciences 927.00
Lupin 2306.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×